JNJ Johnson & JohnsoncompanySEC Filings & Insider Trading Activity 2026
Latest Johnson & Johnson (JNJ) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 11, 2026, a 10-Q quarterly report filed on October 22, 2025, an 8-K current report filed on April 28, 2026, Form 4 insider transactions reported on December 1, 2025. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Johnson & Johnson (JNJ) (SEC CIK 200406), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2025-12-28)
Business Overview
- • Core business model not detailed; filing focuses on corporate governance and compliance policies
- • New emphasis on transparency with online posting of Code of Business Conduct amendments and waivers within five business days
Management Discussion & Analysis
- • Revenue $94.2B in 2025, up 6.0% YoY from $88.8B in 2024; U.S. sales $53.8B (+6.9%), international $40.4B (+5.0%)
- • Operating margin 34.6% in 2025 vs 18.8% in 2024; Innovative Medicine margin 36.9% vs 33.2%; MedTech margin 12.2% vs 11.7%
Risk Factors
- • Board Regulatory Compliance & Sustainability Committee oversees cybersecurity risk and compliance with privacy laws
- • CISO provides quarterly updates on evolving cybersecurity threats and incidents impacting the company and industry
Annual Reports Archive10-K
AI-powered analysis of Johnson & Johnson (JNJ) 10-K annual reports filed with SEC EDGAR.
Financial SummaryXBRL
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $94.9B | $85.2B | $88.8B | $94.2B |
| Gross Profit | $63.9B | $58.6B | $61.4B | $63.9B |
| Net Income | $17.9B | $35.2B | $14.1B | $26.8B |
| Gross Margin | 67.3% | 68.8% | 69.1% | 67.9% |
| Net Margin | 18.9% | 41.3% | 15.8% | 28.5% |
| Balance Sheet | ||||
| Total Assets | $187.4B | $167.6B | $180.1B | $199.2B |
| Equity | $76.8B | $68.8B | $71.5B | $81.5B |
| ROE | 23.4% | 51.1% | 19.7% | 32.9% |
Source: XBRL financial data from Johnson & Johnson (JNJ) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Apr 28, 2026 | — | — | — |
8-K | Apr 14, 2026 | — | — | — |
13F-HR | Feb 13, 2026 | Dec 31, 2025 | — | |
10-K | Feb 11, 2026 | Dec 28, 2025 | Analysis | |
8-K | Jan 21, 2026 | — | — | |
4 | Dec 1, 2025 | — | — | |
4 | Nov 25, 2025 | — | — | |
13F-HR | Nov 13, 2025 | Sep 30, 2025 | — | |
10-Q | Oct 22, 2025 | Sep 28, 2025 | — | |
10-Q | Jul 24, 2025 | Jun 29, 2025 | — | |
13F-HR | Jul 22, 2025 | Jun 30, 2025 | — | |
13F-HR | May 7, 2025 | Mar 31, 2025 | — | |
10-Q | Apr 23, 2025 | Mar 30, 2025 | — | |
13F-HR | Feb 13, 2025 | Dec 31, 2024 | — | |
10-K | Feb 13, 2025 | Dec 29, 2024 | — | |
13F-HR | Nov 13, 2024 | Sep 30, 2024 | — | |
10-Q | Oct 23, 2024 | Sep 29, 2024 | — | |
SC 13G | Oct 18, 2024 | — | — | |
13F-HR | Aug 9, 2024 | Jun 30, 2024 | — | |
SC 13G | Jul 30, 2024 | — | — | |
10-Q | Jul 25, 2024 | Jun 30, 2024 | — | |
13F-HR | May 10, 2024 | Mar 31, 2024 | — | |
10-Q | May 1, 2024 | Mar 31, 2024 | — | |
SC 13G | Apr 10, 2024 | — | — | |
10-K | Feb 16, 2024 | Dec 31, 2023 | — |
Frequently Asked Questions
What are the latest JNJ SEC filings in 2026?
Johnson & Johnson (JNJ) has filed a 10-K annual report on February 11, 2026, a 10-Q quarterly report on October 22, 2025, an 8-K current report on April 28, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did JNJ file its most recent 10-K annual report?
Johnson & Johnson (JNJ) filed its most recent 10-K annual report on February 11, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view JNJ 10-Q quarterly reports?
Johnson & Johnson (JNJ)'s most recent 10-Q quarterly report was filed on October 22, 2025. SignalX displays every JNJ 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has JNJ filed recently?
Johnson & Johnson (JNJ)'s most recent 8-K was filed on April 28, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find JNJ insider trading activity (Form 4)?
The most recent JNJ Form 4 insider transaction on SignalX was filed on December 1, 2025. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock. SignalX aggregates every JNJ Form 4 with transaction code, share count, and price per share.
How often does JNJ file with the SEC?
Johnson & Johnson (JNJ) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new JNJ filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Johnson & Johnson (JNJ).
What is JNJ's SEC CIK number?
Johnson & Johnson (JNJ)'s SEC CIK (Central Index Key) number is 200406. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 200406 to look up all JNJ filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find JNJ return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Johnson & Johnson (JNJ) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Johnson & Johnson SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 70+ filings.